- Acadia Pharmaceuticals (ACAD) will report Q3 2026 financial results after market close on November 4, 2026.
Acadia Pharmaceuticals (ACAD) will report Q3 2026 financial results after market close on November 4, 2026, and host a conference call at 4:30 p.m. ET. No financial figures were provided.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.